Serum Adiponectin Levels in High School Girls with Polycystic Ovary Syndrome and Hyperandrogenism

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 2, 2011, Pages 90-93

  Yasar, L ^a   Ekin, M ^a   Gedikbasi, A ^a   Erturk, A D ^a   Savan, K ^a   Ozdemir, A ^a   Temur, M ^a  

^a Bakirkoy Sadi Konuk Training and Research Hospital   (Turkey)

Author keywords

Adiponectin; BMI; Hyperandrogenism; PCOS

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ADIPONECTIN BLOOD LEVEL; ADOLESCENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH SCHOOL STUDENT; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 79952100120     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2010.11.003     Document Type: Article

References (24)

1. Yii M.F., Lim C.E., Luo X., et al. Polycystic ovarian syndrome in adolescence. Gynecol Endocrinol 2009, 25(10):634-639.
2. Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
3. Guzick D. Polycystic ovary syndrome. Obstet Gynecol 2004, 103(1):181-193.
4. Rizzo M., Berneis K., Spinas G., et al. Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril 2009, 91(4Suppl):1563.
5. Cho L.W., Randeva H.S., Atkin S.L. Cardiometabolic aspects of polycystic ovary syndrome. Vasc Health Risk Manag 2007, 3:55.
6. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000, 11:327.
7. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746.
8. Gulcelik N.E., Aral Y., Serter R., et al. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecol Enocrinol 2006, 22:511.
9. Carmina E., Orio F., Palomba S., et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005, 152:389.
10. Okamoto Y., Arita Y., Nishida M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000, 32:47.
11. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057.
12. Yilmaz M., Burkan N., Demirci H., et al. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2009, 25:246.
13. Tsao T.S., Lodish H.F., Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002, 440:213.
14. Orio F., Palomba F., Cascella T., et al. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:2619.
15. Spranger J., Möhlig M., Wegewitz U., et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004, 61:738.
16. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79.
17. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003, 278:9073.
18. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57.
19. Brooks N.L., Moore K.S., Clark R.D., et al. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes Metab 2007, 9:246.
20. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930.
21. Sir-Petermann T., Maliqueo M., Codner E., et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007, 92:4637.
22. Apter D, Bützow T, Laughlin GA, et al: Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab1995; 80:2966.
23. Toulis K.A., Goulis D.G., Farmakiotis D., et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009, 15:297.
24. Pinhas Hamiel O., Singer S., Pilpel N., et al. Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2009, 71:823.